Blog
About

276
views
0
recommends
+1 Recommend
0 collections
    4
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

      Science (New York, N.Y.)

      metabolism, tau Proteins, therapeutic use, Protease Inhibitors, pathology, Plaque, Amyloid, Neurons, Neurofibrillary Tangles, Nerve Degeneration, Molecular Sequence Data, Humans, Clinical Trials as Topic, Brain, Anticholesteremic Agents, Anti-Inflammatory Agents, Animals, genetics, chemistry, Amyloid beta-Protein Precursor, Amyloid beta-Peptides, Amino Acid Sequence, etiology, drug therapy, Alzheimer Disease

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          It has been more than 10 years since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid beta-peptide (Abeta) in plaques in brain tissue. According to the amyloid hypothesis, accumulation of Abeta in the brain is the primary influence driving AD pathogenesis. The rest of the disease process, including formation of neurofibrillary tangles containing tau protein, is proposed to result from an imbalance between Abeta production and Abeta clearance.

          Related collections

          Author and article information

          Journal
          10.1126/science.1072994
          12130773

          Comments

          Comment on this article